Evaluation of fluoroscopically guided transforaminal epidural steroid injections for cervical radiculopathy utilizing patient reported outcome measurement information system as an outcome measure

利用患者报告结局测量信息系统作为结局指标,评估荧光透视引导下经椎间孔硬膜外类固醇注射治疗颈椎神经根病的效果。

阅读:1

Abstract

BACKGROUND: Cervical radiculopathy is a common cause of pain. For patients who fail conservative management, a transforaminal epidural steroid injection (TFESI) is an accepted intervention and alternative to decompression surgery. OBJECTIVE: The purpose of this study was to evaluate the therapeutic effect of TFESIs for patients with cervical radiculopathy. METHODS: Adult patients treated at a multidisciplinary, tertiary academic spine center with cervical radicular pain and MRI evidence of corroborative cervical spondylotic foraminal stenosis and who had failed at least 6 weeks of conservative management consisting of medication and physical rehabilitation were included in this study. Patient Reported Outcome Measurement Information System (PROMIS) domains of Physical Function (PF) v1.2/v2.0 and Pain Interference (PI) v1.1 were collected at baseline and at 3-, 6-, and 12-month follow-up visits. Statistical analysis comparing baseline score with follow-up post-procedural PROMIS scores was performed. The percentage of patients who reported improvement exceeding the minimal clinically important difference was calculated for survey responders and for the worst case scenario. RESULTS: 87 patients met inclusion criteria. PROMIS PI at 3-, 6-, and 12-months follow-up statistically improved by 2.2 (95 % confidence interval [CI] 2.1-2.4, p = 0.02), 2.3 (95 % CI 2.1-2.5, p = 0.03), and 2.7 (95 % CI 2.5-3.0, p = 0.03) points, respectively. Follow-up PROMIS PF score did not significantly differ from baseline scores. The percentage of patients that exceeded MCID thresholds of clinical significance was 59 % (95 % CI 47%-70 %) at 3-months, 52 % (95 % CI 41%-63 %) at 6-months, and 60 % (95 % CI 50%-72 %) at 12-months. Worst case scenario analysis demonstrated that 51 % (95 % CI 39%-62 %) of patients exceeded the MCID thresholds at 3-months, 32 % (95 % CI 22%-43 %) at 6-months, and 23 % (95 % CI 13%-33 %) at 12-months. CONCLUSIONS: Our study demonstrated that TFESI leads to a long-term improvement up to a year in pain for patients with cervical radiculopathy.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。